Curlyrnd / Wikimedia Commons The retreat also includes the wider problem of declining EV sales because of the loss of the tax credit. iSeeCars expects that 8% of all new vehicles sold in the United States in the third quarter were EVs. It expects that figure to drop to 4% in the fourth quarter and well into next year. Add to these challenges the usual ones of range, tire wear, and lack of public charging stations. Rivian stock is down 6% this year. The broader market is up 16%. Even shares of Tesla Inc. (NA ...

For investors seeking exposure to an evolving, high-potential sector, monitoring earnings trends, company financials, and brand strength can reveal which companies are positioned to benefit most as the market ripens. 2026 could very well be a turning point—one where patience and smart positioning in quality cannabis stocks could pay off as legalization momentum and consumer demand continue to grow. Below are some top marijuana stocks to watch today. Top Marijuana Stocks Today In The Market Here's What Marij ...

Holiday brew for every occasion From bustling holiday parties to cozy fireside nights, Sam Adams has the perfect beer for all your winter drinking occasions with the Winter Break Variety Pack. The seasonal assortment includes Winter White Ale, Winter Lager, Old Fezziwig, and NEW Cold Brew Coffee Stout. A Spiced & Citrusy White Ale Made to Celebrate the Holiday Season BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Samuel Adams, one of the pioneers of craft beer, is gifting drinkers its first new winter seasonal i ...

BREAKING: Futures Mixed After Jobs Data, Novo Nordisk (NVO) stock skidded early Wednesday after the Wegovy and Ozempic maker cut its sales outlook for the third time this year. The Danish drugmaker now expects sales to grow 8% to 11%, narrowed from its guidance three months ago for 8% to 14% growth, in constant currency. At the end of last year, Novo had expected 2025 sales to increase 16% to 24%. Novo's guidance cut follows a disappointing third-quarter showing. Sales came in at about $11.54 billion, base ...

Michael Burry is the billionaire investor famous for predicting the 2008 housing crash immortalized in the book and movie titled, "The Big Short." While he doesn't always short stocks -- Burry's Scion Asset Management hedge fund just bet big on Molina Healthcare (NYSE:MOH) -- it seems that Burry has turned his skeptical eye toward the artificial intelligence (AI) sector. In Scion's recently filed 13F filing, the billionaire disclosed substantial put options on two of the leading AI companies: Palantir Techn ...

Investors aren't excited by Pinterest's revenue forecast. Nikolas Kokovlis / NurPhoto via Getty Images Close Key Takeaways Shares of Pinterest (PINS) plunged after the visual social media and search company missed profit expectations and gave weak holiday quarter guidance. The company posted third-quarter adjusted earnings per share of $0.38, three cents below what analysts surveyed by Visible Alpha were looking for. Revenue rose 17% to $1.05 billion, in line with forecasts. For the current quarter, Pintere ...

MannKind (MNKD) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +200.00%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $0.04 per share when it actually produced break-even earnings, delivering a surprise of -100%. Over the last four quarte ...

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. That said, let's delve into the average estimates of some Main Street Capital metrics that Wall Street analysts commonly model and monitor. Analysts on Wall Street project that Main Street Capital (MAIN) will announce quarterly earnings of $1.04 per share in its forthcoming report, representing an increas ...

NewAmsterdam Pharma Company N.V. (NAMS) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items. While NewAmsterdam Pharma Company N.V. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors ad ...

That said, let's delve into the average estimates of some Paramount Skydance metrics that Wall Street analysts commonly model and monitor. Based on the collective assessment of analysts, 'Revenues- TV Media' should arrive at $3.94 billion. The estimate indicates a year-over-year change of -8.4%. It is projected by analysts that the 'Revenues- Filmed Entertainment' will reach $647.98 million. The estimate indicates a year-over-year change of +9.8%. According to the collective judgment of analysts, 'Revenues- ...